drugset / Trial / NCT00799838

Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal Tonsillitis in Pediatric Patients

NCT00799838

Phase 4 Terminated 106 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the inflammatory symptoms and signs (hyperemia, edema and pain) reduction after 24 hours of treatment with ketoprofen drops when associated to amoxicillin.

Timeline

Start
2008-11
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoprofen Small molecule Oral
Background Amoxicillin Other / unclassified 20 mg/kg Oral
Background Amoxicillin Other / unclassified 40 mg/kg Oral